Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engensis (VM202) in painful diabetic peripheral neuropathy
NCT01475786Phase 2Completed
- Sponsor
- Helixmith
- Start
- Aug 2012
- Primary completion
- Mar 2014
- Modality
- Gene Editing, Gene Silencing, Plasmid DNA
- Countries
- 2
01
Overview
A Phase 2 trial of Engensis in diabetic peripheral neuropathy (DPN), sponsored by Helixmith. Started Aug 2012; status: completed.
02
Drugs
Engensis
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01475786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475786.